|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.170 EUR | -0.91% |
|
+0.46% | -15.89% |
| 05-07 | Cellularline ends quarter with stable revenues | AN |
| 05-06 | Cellularline confirms Christian Aleotti as vice-chairman and CEO | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.1 | -0.67 | 1.15 | 1.8 | 0.81 | |||||
Return on Total Capital | 0.11 | -0.77 | 1.42 | 2.26 | 1.03 | |||||
Return On Equity % | -1.86 | -44.76 | 2.71 | 4.16 | -31.1 | |||||
Return on Common Equity | -1.86 | -44.76 | 2.71 | 4.16 | -31.1 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 45.23 | 38.81 | 38.57 | 40.07 | 40.5 | |||||
SG&A Margin | 44.83 | 40.74 | 35.96 | 36.05 | 38.86 | |||||
EBITDA Margin % | 9.1 | 5.13 | 9.26 | 10.47 | 8.38 | |||||
EBITA Margin % | 8.2 | 4.41 | 8.22 | 9.41 | 7.38 | |||||
EBIT Margin % | 0.4 | -1.93 | 2.61 | 4.02 | 1.65 | |||||
Income From Continuing Operations Margin % | -3.48 | -54.61 | 2.27 | 3.44 | -23.2 | |||||
Net Income Margin % | -3.48 | -54.61 | 2.27 | 3.44 | -23.2 | |||||
Net Avail. For Common Margin % | -3.48 | -54.61 | 2.27 | 3.44 | -23.2 | |||||
Normalized Net Income Margin | 1.37 | 0.28 | 1.67 | 2.39 | 1.71 | |||||
Levered Free Cash Flow Margin | 11.01 | -0.17 | 5.85 | 9.85 | 7.36 | |||||
Unlevered Free Cash Flow Margin | 11.68 | 0.38 | 6.9 | 10.68 | 7.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.55 | 0.71 | 0.72 | 0.78 | |||||
Fixed Assets Turnover | 11.68 | 12.88 | 13.26 | 14.69 | 16.62 | |||||
Receivables Turnover (Average Receivables) | 2.11 | 2.61 | 3.03 | 3.05 | 2.91 | |||||
Inventory Turnover (Average Inventory) | 1.91 | 2.34 | 2.21 | 2.27 | 2.44 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.56 | 1.98 | 1.68 | 2.22 | 2.2 | |||||
Quick Ratio | 1.65 | 1.17 | 0.91 | 1.4 | 1.38 | |||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.09 | 0.17 | 0.38 | 0.35 | |||||
Days Sales Outstanding (Average Receivables) | 173 | 139.76 | 120.5 | 120 | 125.54 | |||||
Days Outstanding Inventory (Average Inventory) | 191.29 | 155.85 | 165.41 | 161.01 | 149.46 | |||||
Average Days Payable Outstanding | 110.88 | 83.3 | 99.07 | 128.15 | 123.16 | |||||
Cash Conversion Cycle (Average Days) | 253.42 | 212.31 | 186.83 | 152.85 | 151.84 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 22.18 | 38.61 | 36.95 | 31.45 | 37.82 | |||||
Total Debt / Total Capital | 18.15 | 27.86 | 26.98 | 23.92 | 27.44 | |||||
LT Debt/Equity | 16.14 | 19.29 | 13.12 | 20.37 | 18.23 | |||||
Long-Term Debt / Total Capital | 13.21 | 13.92 | 9.58 | 15.49 | 13.23 | |||||
Total Liabilities / Total Assets | 26.97 | 39.44 | 42.31 | 39.32 | 44.29 | |||||
EBIT / Interest Expense | 0.38 | -2.17 | 1.54 | 3.06 | 1.71 | |||||
EBITDA / Interest Expense | 9.31 | 7.04 | 6.13 | 8.74 | 9.79 | |||||
(EBITDA - Capex) / Interest Expense | 5.07 | 3.27 | 4.3 | 6.28 | 6.05 | |||||
Total Debt / EBITDA | 4.16 | 5.85 | 3.03 | 2.28 | 2.47 | |||||
Net Debt / EBITDA | 3.41 | 4.7 | 2.18 | 1.18 | 0.88 | |||||
Total Debt / (EBITDA - Capex) | 7.64 | 12.58 | 4.32 | 3.18 | 4 | |||||
Net Debt / (EBITDA - Capex) | 6.27 | 10.1 | 3.1 | 1.65 | 1.42 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.77 | 24.48 | 15.26 | 3.54 | -4.64 | |||||
Gross Profit, 1 Yr. Growth % | 11.32 | 10.81 | 25.4 | 7.57 | -3.61 | |||||
EBITDA, 1 Yr. Growth % | -7.55 | -32.49 | 47.05 | 8.66 | -29.5 | |||||
EBITA, 1 Yr. Growth % | -0.72 | -29.08 | 49.27 | 9.15 | -31.52 | |||||
EBIT, 1 Yr. Growth % | 2.68K | 96.01 | -255.8 | 59.34 | -60.97 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -127.67 | 1.85K | -104.78 | 57.08 | -743.67 | |||||
Net Income, 1 Yr. Growth % | -127.67 | 1.85K | -104.78 | 57.08 | -743.67 | |||||
Normalized Net Income, 1 Yr. Growth % | 49.63 | -1.62 | 599.01 | 47.39 | -31.66 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -127.4 | 1.82K | -104.65 | 53.06 | -769.23 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.11 | 2.25 | -3.44 | 9.31 | -8.45 | |||||
Inventory, 1 Yr. Growth % | -7.42 | 35.66 | 13.36 | -15.45 | -7.65 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.26 | 30.81 | -2.51 | -10.64 | -21.34 | |||||
Total Assets, 1 Yr. Growth % | -4.38 | -23.39 | 8.35 | -3.22 | -23.17 | |||||
Tangible Book Value, 1 Yr. Growth % | 28.73 | 16.99 | 9.83 | 21.68 | 12.49 | |||||
Common Equity, 1 Yr. Growth % | -1.49 | -36.47 | 3.21 | 1.79 | -29.47 | |||||
Cash From Operations, 1 Yr. Growth % | 68.67 | -74.37 | 166.86 | 65 | -9.99 | |||||
Capital Expenditures, 1 Yr. Growth % | -50.87 | -7.76 | 6.16 | 8.46 | 6.41 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -2.7K | -102.17 | -3.98K | 74.45 | -28.82 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.9K | -95.55 | 1.99K | 60.1 | -28.92 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | 6.9 | 16.13 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -11.27 | 14.75 | 19.78 | 9.24 | -0.63 | |||||
Gross Profit, 2 Yr. CAGR % | -12.02 | 9.05 | 12.66 | 16.14 | 1.82 | |||||
EBITDA, 2 Yr. CAGR % | -40.63 | -19.47 | 18.51 | 31.2 | -8.92 | |||||
EBITA, 2 Yr. CAGR % | -41.9 | -18.45 | 23.38 | 33.08 | -9.65 | |||||
EBIT, 2 Yr. CAGR % | -84.63 | 1.19K | 74.75 | 57.67 | -21.14 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -54.04 | 132.54 | -3.32 | -72.59 | 217.97 | |||||
Net Income, 2 Yr. CAGR % | -54.04 | 132.54 | -3.32 | -72.59 | 217.97 | |||||
Normalized Net Income, 2 Yr. CAGR % | -65.25 | -38.66 | 162.24 | 221.21 | 0.36 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -54.05 | 129.38 | -5.47 | -73.31 | 220.06 | |||||
Accounts Receivable, 2 Yr. CAGR % | -7.45 | 0.56 | -0.63 | 2.74 | 0.04 | |||||
Inventory, 2 Yr. CAGR % | 15.38 | 12.07 | 24.01 | -2.1 | -11.63 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.73 | 11.91 | 12.93 | -6.67 | -16.16 | |||||
Total Assets, 2 Yr. CAGR % | -4.32 | -14.41 | -8.89 | 2.4 | -13.77 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.62 | 22.72 | 13.35 | 15.63 | 17 | |||||
Common Equity, 2 Yr. CAGR % | 0.7 | -20.89 | -19.02 | 2.5 | -15.27 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.23 | -34.24 | -17.29 | 109.84 | 21.87 | |||||
Capital Expenditures, 2 Yr. CAGR % | -22.47 | -32.68 | -1.05 | 7.31 | 7.43 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 68.33 | -28.53 | -8.39 | 722.35 | 11.43 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 55.32 | -9.92 | -3.62 | 477.97 | 6.68 | |||||
Dividend Per Share, 2 Yr. CAGR % | -61.08 | - | 31.91 | - | 11.42 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.63 | -0.67 | 14.92 | 14.1 | 4.4 | |||||
Gross Profit, 3 Yr. CAGR % | 1.73 | -6.14 | 10.85 | 10.93 | 9.14 | |||||
EBITDA, 3 Yr. CAGR % | -25.72 | -37.23 | 10.5 | 18.02 | 9.53 | |||||
EBITA, 3 Yr. CAGR % | -27.78 | -39.07 | 12.6 | 21.78 | 9.82 | |||||
EBIT, 3 Yr. CAGR % | -71.9 | -47.96 | 537.12 | 69.54 | -1 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -50.84 | 60.42 | -36.29 | 13.66 | -21.51 | |||||
Net Income, 3 Yr. CAGR % | -50.84 | 60.42 | -36.29 | 13.66 | -21.51 | |||||
Normalized Net Income, 3 Yr. CAGR % | -55.09 | -68.8 | 38.03 | 116.52 | 91.76 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -53.18 | 59.44 | -37.44 | 11 | -21.88 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.28 | -4.32 | -0.79 | 2.58 | -1.13 | |||||
Inventory, 3 Yr. CAGR % | 13.97 | 21.78 | 12.5 | 9.15 | -3.98 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.61 | 10.63 | 6.88 | 4.45 | -11.84 | |||||
Total Assets, 3 Yr. CAGR % | -3.47 | -11.15 | -7.41 | -7.04 | -6.95 | |||||
Tangible Book Value, 3 Yr. CAGR % | 17.39 | 9.28 | 18.26 | 16.08 | 14.58 | |||||
Common Equity, 3 Yr. CAGR % | 1.85 | -13.63 | -13.55 | -12.61 | -9.51 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.43 | -37.85 | 4.89 | 4.12 | 58.25 | |||||
Capital Expenditures, 3 Yr. CAGR % | 36.43 | -17.85 | -21.64 | 2.03 | 7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.82 | -61.81 | 170.51 | 13.56 | 263.77 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -4.23 | -53.88 | 156.75 | 14.16 | 187.43 | |||||
Dividend Per Share, 3 Yr. CAGR % | -44.97 | - | - | 22.98 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -7.05 | -0.26 | 11.08 | 3.18 | 8.42 | |||||
Gross Profit, 5 Yr. CAGR % | -11.73 | -5.65 | 5.2 | 0.37 | 7.15 | |||||
EBITDA, 5 Yr. CAGR % | -23.35 | -28.71 | -9.77 | -9.65 | 3.81 | |||||
EBITA, 5 Yr. CAGR % | -23.81 | -29.69 | -11.54 | -10.45 | 4.84 | |||||
EBIT, 5 Yr. CAGR % | -58.3 | -40.41 | -27.06 | -18.92 | 176.31 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -29.25 | 26 | -35.57 | -20.88 | 21.2 | |||||
Net Income, 5 Yr. CAGR % | -29.25 | 26 | -35.57 | -20.88 | 21.2 | |||||
Normalized Net Income, 5 Yr. CAGR % | -40.08 | -55.29 | -30.76 | -20.72 | 21.55 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 156.78 | -37.99 | -22 | 20.19 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.64 | -6.34 | -2.84 | -1.56 | -0.46 | |||||
Inventory, 5 Yr. CAGR % | 13.81 | 18.43 | 17.89 | 11.6 | 2.14 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.66 | 10.07 | 10.31 | 3.35 | -3.01 | |||||
Total Assets, 5 Yr. CAGR % | 5.51 | -0.13 | -5.68 | -5.96 | -10.01 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.06 | 78.32 | 15.76 | 11.78 | 17.77 | |||||
Common Equity, 5 Yr. CAGR % | 7.79 | 4.46 | -7.08 | -7.51 | -14.24 | |||||
Cash From Operations, 5 Yr. CAGR % | -9.39 | -25.62 | 0.5 | 1.11 | 11.38 | |||||
Capital Expenditures, 5 Yr. CAGR % | 35.82 | 27.18 | 19.98 | -8.58 | -11.1 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -12.4 | -57.78 | -8.06 | 30.37 | 89.73 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -13.65 | -51.31 | -5.72 | 26.79 | 80.7 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | -21.93 | -22.38 | - |
- Stock Market
- Stocks
- CELL Stock
- Financials Cellularline S.p.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















